As per the research report, the Size of the MEA Hemodialysis Catheters Market is valued at USD 36.30 million in 2023 and is expected to grow at a CAGR of 2.53%, reaching USD 41.12 million by 2028 during the forecast period 2023 to 2028.
Factors such as the increasing frequency of end-stage renal disease (ESRD) and the rising number of patients who suffers from chronic kidney disease propel the growth Middle East Africa hemodialysis catheters market.
Moreover, the market expansion is expected to be fueled by technological advancements in these catheters and a lack of kidney donors.
Other vital factors expected to fuel the growth of the Hemodialysis Catheters Market include an increase in the incidence of chronic kidney disease and related risk determinants such as diabetes, cardiovascular disease, and hypertension. Furthermore, an increase in the popularity of antimicrobial-coated hemodialysis catheters, an increase in R&D spending for developing novel hemodialysis products, and an increase in the desire for home hemodialysis (HHD) treatment are all the factors that contribute to the growth of the market.
Final renal disease (ESRD) is becoming more common, and fewer kidney donors are available for transplantation. In addition, patients with CKD have a weakened immune system, making them more susceptible to infections. The danger of infection is substantial because these individuals require regular hospitalization for dialysis. As a result of these increased concerns, vendors are introducing antimicrobial catheters to lower the risk of infection. The launch of such novel products is expected to boost the MEA hemodialysis catheters market during the projected period.
Limitations hamper the market's growth in medical reimbursement for dialysis procedures in this country and an increased risk of blood infection and thrombosis. Infection is the leading cause of death in ESRD patients, and using vascular devices in hemodialysis is the most risky factor for infection.
The market's expansion is predicted to be hampered by problems associated with hemodialysis catheters and a lack of access to hemodialysis catheters in this nation. There are various side effects of hemodialysis treatment, including itching, infections, anemia, pericarditis, hyperkalemia, hypotension, hypertension, muscular cramps, and bone problems. Inadequate waste filtering, the creation of clots in the dialysis graft or fistula, and the emergence of cardiovascular disease or cardiac arrhythmias are some of the other long-term concerns associated with hemodialysis.
This research report on the Middle East & Africa Hemodialysis Catheters Market has been segmented and sub-segmented into the following categories.
By Product:
By Tip Configuration:
By Material:
By End User:
By Country:
Geographically, the MEA Hemodialysis Catheters Market is expected to increase at the fastest rate due to a vast patient pool and advanced knowledge of the benefits of dialysis; the Middle East Africa market has enormous prospects for the dialysis business.
Furthermore, hypertension in diabetic individuals increases the risk of vascular problems, and combined disorders can lead to chronic kidney disease.
KEY MARKET PLAYERS
Key Market Companies dominating the MEA Hemodialysis Catheters Market Profiled in the Report are Nipro Medical Corporation, Fresenius Medical Care AG & Co. KGaA, Toray Medical Co., Ltd., Nikkiso Co. Ltd, Baxter International Inc., B. Braun Melsungen AG, Asahi Kasei Medical Co., Ltd.,
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region